Covered recipient · General Payments record
MOHAMED GALAL SALEH
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$3,864.62
- Reported across 196 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $549.96 | 26 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $111.28 | 5 |
| Indivior Inc. | $94.10 | 5 |
| Otsuka America Pharmaceutical, Inc. | $91.03 | 4 |
| PFIZER INC. | $82.96 | 4 |
| DEXCOM, INC. | $36.81 | 1 |
| Novo Nordisk AS | $32.44 | 2 |
| Braeburn Inc. | $28.48 | 2 |
| Janssen Pharmaceuticals, Inc | $26.14 | 1 |
| USWM, LLC | $25.52 | 1 |
| Teva Pharmaceuticals USA, Inc. | $21.20 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (26)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $18.98 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106005289 | CMS |
| ABBVIE INC. | $23.01 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106005291 | CMS |
| ABBVIE INC. | $26.91 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106005293 | CMS |
| ABBVIE INC. | $22.52 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106005295 | CMS |
| ABBVIE INC. | $19.86 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106005297 | CMS |
| Braeburn Inc. | $14.20 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125605471 | CMS |
| Braeburn Inc. | $14.28 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125605469 | CMS |
| Dexcom, Inc. | $36.81 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153323630 | CMS |
| Indivior Inc. | $19.99 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144537346 | CMS |
| Indivior Inc. | $22.32 | 04/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144537348 | CMS |
| Indivior Inc. | $17.68 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144537350 | CMS |
| Indivior Inc. | $17.60 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144537352 | CMS |
| Indivior Inc. | $16.51 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144537354 | CMS |
| Janssen Pharmaceuticals, Inc | $26.14 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078051130 | CMS |
| Novo Nordisk Inc | $15.47 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096926310 | CMS |
| Novo Nordisk Inc | $16.97 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097554606 | CMS |
| Otsuka America Pharmaceutical, Inc. | $23.27 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118974820 | CMS |
| Otsuka America Pharmaceutical, Inc. | $22.63 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118974822 | CMS |
| Otsuka America Pharmaceutical, Inc. | $25.08 | 05/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118974824 | CMS |
| Otsuka America Pharmaceutical, Inc. | $20.05 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118974826 | CMS |
| PFIZER INC. | $21.52 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132033955 | CMS |
| PFIZER INC. | $21.51 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132033957 | CMS |
| PFIZER INC. | $21.52 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132036190 | CMS |
| PFIZER INC. | $18.41 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130882816 | CMS |
| Teva Pharmaceuticals USA, Inc. | $21.20 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151615082 | CMS |
| USWM, LLC | $25.52 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152821643 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.